Use of tetrahydropterins in the treatment of hyperphenylalaninemia due to defective synthesis of tetrahydrobiopterin: Evidence that peripherally administered tetrahydropterins enter the brain

S. Kaufman, G. Kapatos, R. R. McInnes, J. D. Schulman, W. B. Rizzo

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Substantial amounts of tetrahydrobiopterin and 6-methyltetrahydropterin can be detected in CSF when these pterins are given peripherally to patients with hyperphenylalaninemia due to defective biopterin synthesis. Results of this study suggest that administration of either of these pterins in proper doses may prove to be a treatment not only for the impaired peripheral phenylalanine metabolism, but also for the neurologic disorders that are characteristic of the variant forms of hyperphenylalaninemia due to defective tetrahydrobiopterin synthesis or metabolism.

Original languageEnglish (US)
Pages (from-to)376-380
Number of pages5
JournalPediatrics
Volume70
Issue number3
StatePublished - Oct 25 1982

Fingerprint

Pterins
Phenylketonurias
Biopterin
Brain
Nervous System Diseases
Phenylalanine
Therapeutics
tetrahydropterin
sapropterin
6-methyltetrahydropterin

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Use of tetrahydropterins in the treatment of hyperphenylalaninemia due to defective synthesis of tetrahydrobiopterin : Evidence that peripherally administered tetrahydropterins enter the brain. / Kaufman, S.; Kapatos, G.; McInnes, R. R.; Schulman, J. D.; Rizzo, W. B.

In: Pediatrics, Vol. 70, No. 3, 25.10.1982, p. 376-380.

Research output: Contribution to journalArticle

@article{48b1dd5da30347a79d42493dbcaea48d,
title = "Use of tetrahydropterins in the treatment of hyperphenylalaninemia due to defective synthesis of tetrahydrobiopterin: Evidence that peripherally administered tetrahydropterins enter the brain",
abstract = "Substantial amounts of tetrahydrobiopterin and 6-methyltetrahydropterin can be detected in CSF when these pterins are given peripherally to patients with hyperphenylalaninemia due to defective biopterin synthesis. Results of this study suggest that administration of either of these pterins in proper doses may prove to be a treatment not only for the impaired peripheral phenylalanine metabolism, but also for the neurologic disorders that are characteristic of the variant forms of hyperphenylalaninemia due to defective tetrahydrobiopterin synthesis or metabolism.",
author = "S. Kaufman and G. Kapatos and McInnes, {R. R.} and Schulman, {J. D.} and Rizzo, {W. B.}",
year = "1982",
month = "10",
day = "25",
language = "English (US)",
volume = "70",
pages = "376--380",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "3",

}

TY - JOUR

T1 - Use of tetrahydropterins in the treatment of hyperphenylalaninemia due to defective synthesis of tetrahydrobiopterin

T2 - Evidence that peripherally administered tetrahydropterins enter the brain

AU - Kaufman, S.

AU - Kapatos, G.

AU - McInnes, R. R.

AU - Schulman, J. D.

AU - Rizzo, W. B.

PY - 1982/10/25

Y1 - 1982/10/25

N2 - Substantial amounts of tetrahydrobiopterin and 6-methyltetrahydropterin can be detected in CSF when these pterins are given peripherally to patients with hyperphenylalaninemia due to defective biopterin synthesis. Results of this study suggest that administration of either of these pterins in proper doses may prove to be a treatment not only for the impaired peripheral phenylalanine metabolism, but also for the neurologic disorders that are characteristic of the variant forms of hyperphenylalaninemia due to defective tetrahydrobiopterin synthesis or metabolism.

AB - Substantial amounts of tetrahydrobiopterin and 6-methyltetrahydropterin can be detected in CSF when these pterins are given peripherally to patients with hyperphenylalaninemia due to defective biopterin synthesis. Results of this study suggest that administration of either of these pterins in proper doses may prove to be a treatment not only for the impaired peripheral phenylalanine metabolism, but also for the neurologic disorders that are characteristic of the variant forms of hyperphenylalaninemia due to defective tetrahydrobiopterin synthesis or metabolism.

UR - http://www.scopus.com/inward/record.url?scp=0019964391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019964391&partnerID=8YFLogxK

M3 - Article

C2 - 7110811

AN - SCOPUS:0019964391

VL - 70

SP - 376

EP - 380

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 3

ER -